Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ERYP - Erytech Pharma - ADR


Close
0.79
-0.030   -3.797%

Share volume: 0
Last Updated: Thu 29 Jun 2023 10:00:00 PM CEST
Biological Product (except Diagnostic) Manufacturing : -3.41%

PREVIOUS CLOSE
CHG
CHG%

$0.82
-0.03
-3.66%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
76%
Profitability 93%
Dept financing 25%
Liquidity 0%
Performance 90%
Performance
5 Days
-10.86%
1 Month
-10.02%
3 Months
-15.50%
6 Months
136.29%
1 Year
-31.58%
2 Year
-83.58%
Key data
Stock price
$0.79
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.30 - $1.47
52 WEEK CHANGE
-$0.30
MARKET CAP 
26.614 M
YIELD 
N/A
SHARES OUTSTANDING 
34.120 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$9,885
AVERAGE 30 VOLUME 
$10,526
Company detail
CEO: Gil Beyen
Region: US
Website: http://erytech.com/
Employees: 181
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing

Recent news